EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bridging basic science and applied diagnostics: Comprehensive viral diagnostics enabled by graphene-based electronic biosensor technology advancements

Anna Nele Herdina, Anil Bozdogan, Patrik Aspermair, Jakub Dostalek, Miriam Klausberger, Nico Lingg, Monika Cserjan-Puschmann, Patricia Pereira Aguilar, Simone Auer, Halil Demirtas, Jakob Andersson, Felix Lötsch und 7 weitere

Biosensors and Bioelectronics · 2025

DOI: 10.1016/j.bios.2024.116807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Anna Nele Herdina und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Biosensing Techniques, Graphite, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents a graphene field-effect transistor (gFET) biosensor with dual detection capabilities for SARS-CoV-2: one RNA detection assay to confirm viral positivity and the other for nucleocapsid (N-)protein detection as a proxy for infectiousness of the patient. This technology can be rapidly adapted to emerging infectious diseases, making an essential tool to contain future pandemics. To detect viral RNA, the highly conserved E-gene of the virus was targeted, allowing for the determination of SARS-CoV-2 presence or absence using nasopharyngeal swab samples. For N-protein detection, specific antibodies were used. Tested on 213 clinical nasopharyngeal samples, the gFET biosensor showed good correlation with RT-PCR cycle threshold values, proving its high sensitivity in detecting SARS-CoV-2 RNA. Specificity was confirmed using 21 pre-pandemic samples positive for other respiratory viruses. The gFET biosensor had a limit of detection (LOD) for N-protein of 0.9 pM, establishing a foundation for the development of a sensitive tool for monitoring active viral infection. Results of gFET based N-protein detection corresponded to the results of virus culture in all 16 available clinical samples and thus it also proved its capability to serve as a proxy for infectivity. Overall, these findings support the potential of the gFET biosensor as a point-of-care device for rapid diagnosis of SARS-CoV-2 infection and indirect assessment of infectiousness in patients, providing additional information for clinical and public health decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesGraphiteSARS-CoV-2COVID-19RNA, ViralHumansLimit of DetectionCoronavirus Nucleocapsid ProteinsTransistors, ElectronicPhosphoproteinsNasopharynxEquipment Design

Stichwörter der Autor:innen

COVID-19DiagnosticsGraphene field-effect transistorInfectivityNucleocapsid proteinSARS-CoV-2

Substanzen

GraphiteRNA, Viralnucleocapsid phosphoprotein, SARS-CoV-2Coronavirus Nucleocapsid ProteinsPhosphoproteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Vienna, Austria.
  • Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Vienna, Austria; BioSensor Technologies, Austrian Institute of Technology, Vienna, Austria.
  • BioSensor Technologies, Austrian Institute of Technology, Vienna, Austria; Life Sciences Technology, Danube Privat University, Wiener Neustadt, Austria.
  • Life Sciences Technology, Danube Privat University, Wiener Neustadt, Austria; Institute of Physics, Czech Academy of Sciences, Prague, Czech Republic.
  • Department of Biotechnology, BOKU University, Vienna, Austria.
  • ACIB - Austrian Centre of Industrial Biotechnology, Vienna, Austria; Department of Biotechnology, Institute of Bioprocess Science and Engineering, BOKU University, Vienna, Austria.

Förderung

  • Austrian Science Fund FWF
  • Austrian Science Fund

Zitieren

APA

Herdina, A. N., Bozdogan, A., Aspermair, P., Dostalek, J., Klausberger, M., Lingg, N., Cserjan-Puschmann, M., Aguilar, P. P., Auer, S., Demirtas, H., Andersson, J., Lötsch, F., Holzer, B., Steinrigl, A., Thalhammer, F., Schellnegger, J., Breuer, M., Knoll, W., & Strassl, R. (2025). Bridging basic science and applied diagnostics: Comprehensive viral diagnostics enabled by graphene-based electronic biosensor technology advancements. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2024.116807

Vancouver

Herdina AN, Bozdogan A, Aspermair P, Dostalek J, Klausberger M, Lingg N, et al. Bridging basic science and applied diagnostics: Comprehensive viral diagnostics enabled by graphene-based electronic biosensor technology advancements. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2024.116807

BibTeX
@article{Herdina2025,
  author = {Herdina, Anna Nele and Bozdogan, Anil and Aspermair, Patrik and Dostalek, Jakub and Klausberger, Miriam and Lingg, Nico and Cserjan-Puschmann, Monika and Aguilar, Patricia Pereira and Auer, Simone and Demirtas, Halil and Andersson, Jakob and Lötsch, Felix and Holzer, Barbara and Steinrigl, Adi and Thalhammer, Florian and Schellnegger, Julia and Breuer, Monika and Knoll, Wolfgang and Strassl, Robert},
  title = {Bridging basic science and applied diagnostics: Comprehensive viral diagnostics enabled by graphene-based electronic biosensor technology advancements},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  doi = {10.1016/j.bios.2024.116807}
}
Kostenlos starten →